Vaso Occlusive Crisis Associated with Sickle Cell Disease Drug Market Growth, Size, Share, Industry Report and Forecast 2021-2027
The global vaso occlusive crisis associated with sickle cell disease drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The vaso-occlusive crisis associated with sickle cell disease is a common painful complication of sickle cell disease that occurs in adolescents and adults. The major factor driving the growth of the market is the rising prevalence of sickle cell disease across the globe.
According to the Center for
Disease Control and Prevention (CDC), in 2020, SCD affects approximately
100,000 Americans and occurs about 1 out of every 365 Black or African-American
births. Additionally, SCD occurs among about 1 out of every 16,300
Hispanic-American births and about 1 in 13 Black or African-American babies is
born with sickle cell trait (SCT). Hence, the increasing prevalence of SDC is
increasing the risk for vaso occlusive crisis associated with sickle cell
disease which in turn is driving the growth of the market.
To Request a Sample of our Report on Vaso Occlusive
Crisis Associated With Sickle Cell Disease Drug Market: https://www.omrglobal.com/request-sample/vaso-occlusive-crisis-associated-with-sickle-cell-disease-drug-market
Some major players in the market
include AstraZeneca Plc, Bristol-Myers Squibb Co., and Novartis International
AG, among others. The market players are contributing significantly to the
growth of the market by the adoption of various strategies including mergers
& acquisitions, geographical expansion, partnerships and collaborations,
and new product launches, to stay competitive in the market. For instance, in
November 2019, Novartis announced that it has received approval for Adakveo
(crizanlizumab-tmca) from the US FDA. It is used for the treatment to reduce
the frequency of vaso-occlusive crisis associated with sickle cell disease for
patients age 16 years and older.
Market Coverage
•
The market number available for – 2020-2027
•
Base year- 2020
•
Forecast period- 2021-2027
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape-
AstraZeneca Plc, Bristol-Myers Squibb Co., and Novartis International AG, among
others.
(Get 15% Discount on Buying this Report)
A
full Report of Vaso Occlusive Crisis Associated With Sickle Cell Disease Drug
Market is Available @ https://www.omrglobal.com/industry-reports/vaso-occlusive-crisis-associated-with-sickle-cell-disease-drug-market
Global Vaso Occlusive Crisis Associated with Sickle Cell
Disease Drug Market Report by Segment
By Type
•
SGD-2083
•
Crizanlizumab
•
PF-04447943
•
NVX-508
•
Others
By Application
•
Hospital
•
Clinic
•
Other
Global Vaso Occlusive Crisis Associated with Sickle Cell
Disease Drug Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment